Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Start 7-day free trial → Log in

Atogepant · Qulipta, AGN-241689

Small molecule · Antagonist of CGRP receptor · developed by Abbvie

Approved FDA, Sep 2021

ABBV Developer

1 Registered trials

What is Atogepant?

Atogepant is a small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as: Qulipta, AGN-241689, MK-8031, Aquipta
Drug type: Small molecule
Targets: CGRP receptor
Mechanism: Antagonist of CGRP receptor
Therapy area: Neurology
Developer: Abbvie (ABBV)
FDA status: Approved as Qulipta (September 28, 2021), NDA215206 · FDA label
UNII: 7CRV8RR151

✅ FDA-approved uses

Preventive treatment of migraine in adults

From the indications section of the FDA label (version of Sep 30, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

Trial	Phase	Condition	Status	Sponsor
NCT06810505	Phase 3	Chronic Migraine	Recruiting	ABBV

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Chronic Migraine

More from Abbvie

Adalimumab FDA approved Pivekimab Sunirine FDA approved Risankizumab FDA approved Telisotuzumab Vedotin FDA approved Upadacitinib FDA approved Venetoclax FDA approved ABBV-1042 Phase 1 ABBV-291 Phase 1 ABBV-295 Phase 2 ABBV-313 Phase 1 ABBV-324 Phase 1 ABBV-438 Phase 1

Sources

Updated Oct 3, 2026. Something wrong or missing? Report it on the ABBV page.

Follow ABBV, the company behind Atogepant

See ABBV's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

ABBV catalysts and pipeline →

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z